• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因治疗:迈向医学新时代。

Gene Therapy: Towards a New Era of Medicine.

作者信息

Bhagat Mokshit, Kamal Raj, Sharma Jyoti, Kaur Kirandeep, Sharma Amit, Singh Thakur Gurjeet, Bhatia Rohit, Awasthi Ankit

机构信息

Bachlor of Pharmacy, I.S.F College of Pharmacy, Moga, Punjab, India.

School of Pharmacy, Desh Bhagat University, Mandi Gobindgarh, Punjab, 147301, India.

出版信息

AAPS PharmSciTech. 2024 Dec 19;26(1):17. doi: 10.1208/s12249-024-03010-6.

DOI:10.1208/s12249-024-03010-6
PMID:39702810
Abstract

Over the past years, many significant advances have been made in the field of gene therapy and shown promising results in clinical trials conducted. Gene therapy aims at modifying or replacing a defective, inefficient, or nonfunctional gene with a healthy, functional gene by administration of genome material into the cell to cure genetic diseases. Various methods have been devised to do this by using several viral and non-viral vectors which are either administered by in vivo or ex vivo technique. Viral vectors are best suitable for this therapy due to their potential to invade cells and deliver their genetic material whereas non-viral vectors are less efficient than viral vectors but possess some advantages such as less immunogenic response and large gene carrying capacity. Recent advances in biotechnology such as CRISPR-Cas9 mediated genome engineering and Cancer treatment with Chimeric antigen receptor (CAR) T-cell therapy are addressed in this review. This review article also delves into some recent research studies, gene therapy trials, and its applications, laying out future hopes for gene therapy in the treatment of various diseases namely haemophilia, Muscular dystrophy, SCID, Sickle cell disease, Familial Hypercholesterolemia, Cystic Fibrosis. Additionally, it also includes various nanoformulations and clinical trial data related to gene therapy.

摘要

在过去几年中,基因治疗领域取得了许多重大进展,并在进行的临床试验中显示出有前景的结果。基因治疗旨在通过将基因组物质导入细胞,用健康、有功能的基因修饰或替换有缺陷、效率低下或无功能的基因,以治愈遗传疾病。人们已经设计出各种方法来实现这一目标,即使用几种通过体内或体外技术施用的病毒和非病毒载体。病毒载体因其侵入细胞并传递其遗传物质的潜力而最适合这种治疗,而非病毒载体虽然比病毒载体效率低,但具有一些优点,如免疫原性反应较小和基因携带能力大。本文综述了生物技术的最新进展,如CRISPR-Cas9介导的基因组工程和嵌合抗原受体(CAR)T细胞疗法治疗癌症。这篇综述文章还深入探讨了一些近期的研究、基因治疗试验及其应用,阐述了基因治疗在治疗各种疾病(即血友病、肌肉萎缩症、重症联合免疫缺陷病、镰状细胞病、家族性高胆固醇血症、囊性纤维化)方面的未来希望。此外,它还包括与基因治疗相关的各种纳米制剂和临床试验数据。

相似文献

1
Gene Therapy: Towards a New Era of Medicine.基因治疗:迈向医学新时代。
AAPS PharmSciTech. 2024 Dec 19;26(1):17. doi: 10.1208/s12249-024-03010-6.
2
Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.基因治疗与 CRISPR/Cas9 渐趋成熟,有望攻克 HIV。
AIDS Rev. 2017 Oct-Dec;19(3):167-172.
3
Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral Vectors.组织特异性递送 CRISPR 治疗药物:非病毒载体的策略和机制。
Int J Mol Sci. 2020 Oct 5;21(19):7353. doi: 10.3390/ijms21197353.
4
Gene therapy: advances, challenges and perspectives.基因治疗:进展、挑战与展望。
Einstein (Sao Paulo). 2017 Jul-Sep;15(3):369-375. doi: 10.1590/S1679-45082017RB4024.
5
Gene editing and CRISPR in the clinic: current and future perspectives.基因编辑和 CRISPR 在临床中的应用:现状与未来展望。
Biosci Rep. 2020 Apr 30;40(4). doi: 10.1042/BSR20200127.
6
Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.联合病毒转导和 CRISPR/Cas9 基因编辑治疗神经退行性疾病的治疗潜力。
Neurol Sci. 2018 Nov;39(11):1827-1835. doi: 10.1007/s10072-018-3521-0. Epub 2018 Aug 3.
7
Viral Delivery Systems for CRISPR.用于 CRISPR 的病毒递送系统。
Viruses. 2019 Jan 4;11(1):28. doi: 10.3390/v11010028.
8
Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles.CRISPR/Cas介导的癌症治疗递送系统的进展:聚焦于病毒载体和细胞外囊泡
Front Immunol. 2024 Aug 30;15:1444437. doi: 10.3389/fimmu.2024.1444437. eCollection 2024.
9
Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing.近期非病毒 CRISPR/Cas9 基因编辑递送和应用的进展。
Drug Deliv Transl Res. 2023 May;13(5):1500-1519. doi: 10.1007/s13346-023-01320-z. Epub 2023 Mar 29.
10
Delivery of CRISPR/Cas9 for therapeutic genome editing.CRISPR/Cas9 基因编辑治疗的递送。
J Gene Med. 2019 Jul;21(7):e3107. doi: 10.1002/jgm.3107.

引用本文的文献

1
Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies.基于细胞外囊泡的药物概述:研究现状、质量控制及非临床评估策略
Signal Transduct Target Ther. 2025 Aug 14;10(1):255. doi: 10.1038/s41392-025-02312-w.

本文引用的文献

1
Advances in targeting LDL cholesterol: PCSK9 inhibitors and beyond.靶向低密度脂蛋白胆固醇的进展:前蛋白转化酶枯草杆菌蛋白酶/kexin 9型抑制剂及其他。
Am J Prev Cardiol. 2024 Jun 25;19:100701. doi: 10.1016/j.ajpc.2024.100701. eCollection 2024 Sep.
2
Adeno-associated virus as a delivery vector for gene therapy of human diseases.腺相关病毒作为人类疾病基因治疗的递送载体。
Signal Transduct Target Ther. 2024 Apr 3;9(1):78. doi: 10.1038/s41392-024-01780-w.
3
Gene Editing for the Treatment of Hypercholesterolemia.基因编辑治疗高胆固醇血症。
Curr Atheroscler Rep. 2024 May;26(5):139-146. doi: 10.1007/s11883-024-01198-3. Epub 2024 Mar 18.
4
Looking to the Future: Drug Delivery and Targeting in the Prophylaxis and Therapy of Severe and Chronic Diseases.展望未来:严重和慢性疾病预防和治疗中的药物输送和靶向。
Handb Exp Pharmacol. 2024;284:389-411. doi: 10.1007/164_2023_696.
5
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.一项利妥昔单抗联合免疫治疗双联方案用于复发/难治性滤泡性淋巴瘤的多队列1b期试验。
Ann Hematol. 2024 Jan;103(1):185-198. doi: 10.1007/s00277-023-05475-0. Epub 2023 Oct 18.
6
The status of the human gene catalogue.人类基因目录的现状。
Nature. 2023 Oct;622(7981):41-47. doi: 10.1038/s41586-023-06490-x. Epub 2023 Oct 4.
7
Adenovirus as a Vector and Oncolytic Virus.腺病毒作为载体和溶瘤病毒
Curr Issues Mol Biol. 2023 Jun 2;45(6):4826-4840. doi: 10.3390/cimb45060307.
8
Gene therapy in cancer.癌症的基因治疗。
J Gene Med. 2023 Nov;25(11):e3550. doi: 10.1002/jgm.3550. Epub 2023 Jun 24.
9
Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy.在利用病毒和非病毒载体传递用于癌症治疗的遗传和非遗传货物方面的技术进展。
Drug Deliv Transl Res. 2023 Nov;13(11):2719-2738. doi: 10.1007/s13346-023-01362-3. Epub 2023 Jun 10.
10
Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene Therapy.评价腺相关病毒为基础的基因治疗的细胞免疫反应。
AAPS J. 2023 Apr 26;25(3):47. doi: 10.1208/s12248-023-00814-5.